retatrutide trial weight loss results Lilly's triple agonist achieves 16.8% in phase 3 Retatrutide Latest Study Released:: People

Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss

Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in at least 13 other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, South Carolina, Virginia and Wisconsin

Unfortunately, misinformation about these medications has also taken the Internet by storm

This simplifies meal prep while ensuring you meet your nutritional targets

Speaking clearly becomes challenging, which can affect social interactions and professional life

In this blog, well break down what these medications do, how they compare to each other, and what factors might help determine which one is right for you